Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Divine Skin has won Drug Enforcement Agency license in partnership with its manufacturing partner for the production of Ephedrine containing drugs and other controlled substances.
Subscribe to our email newsletter
The company believes that the new OTC analgesic could provide an alternative to current OTC pain relievers.
According to an August 2010 report published by the US Census Bureau the manufacturers’ revenue from internal non-narcotic analgesics, antipyretics, anti-arthritics, and anti-inflammatories, including salicylates and acetaminophen, totaled $2.4bn in 2009, in the US.
Divine Skin develops biotechnology for topical, nutritional and pharmaceutical therapies and markets through online and specialty retailers, cosmetics wholesalers, salons, and medical offices.